Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

ACHILLION PHARMACEUTICALS INC (ACHN)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsDec-31-18Dec-31-17Dec-31-16Dec-31-15Dec-31-14Dec-31-13Dec-31-12Dec-31-11
   10-K10-K10-K10-K10-K10-K10-K10-K
Revenue          
Operating expenses          
Research and development  50.163.656.856.653.546.739.035.4
General and administrative  23.926.023.024.715.912.710.99.2
Restructuring charges (Note 4)  1.9       
    Total operating expenses  75.989.679.981.269.459.549.944.6
    Loss from operations  -75.9-89.6-64.9-15.1-69.4-59.5-47.3-44.3
   
Other income (expense)          
Interest income  5.74.43.21.20.50.60.2 
Interest expense  0.0-0.1-0.1-0.10.0-0.1-0.1 
    Net loss  -70.3-85.2-61.7-5.0-69.0-58.9-47.1-44.2
   
Basic and diluted net loss per share (Note 5)  ($0.51)($0.62)($0.45)($0.04)($0.70)($0.63)($0.64)($0.69)
Total comprehensive loss (Note 9)  -70.1-85.8-61.5-5.1-69.0-59.0-47.1-44.2
   
Weighted average number of shares used in computing basic and diluted net loss per share  138.4137.2136.7125.698.494.074.064.2

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy